Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study. - McLean WJ; Hinton AS; Herby JTJ; Salt AN; Hartsock JJ; Wilson S; Lucchino DL; Lenarz T; Warnecke A; Prenzler N; Schmitt H; King S; et al. (Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2021)